CVS Health posts strong Q4 revenue, raises full-year guidance

robot
Abstract generation in progress

CVS Health (NYSE:CVS) reported stronger-than-expected fourth-quarter revenue of $105.7 billion and adjusted earnings per share of $1.09, driven by growth across its pharmacy, health services, and insurance segments. The company also confirmed its full-year 2026 adjusted EPS guidance of $7 to $7.20, slightly above analyst estimates. CEO David Joyner highlighted progress in transforming healthcare through drug price reduction and improved navigation.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
  • Pin

Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate App
Community
English
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)